tm
Seeing Is Believing
tm
Seeing Is Believing
MREO is currently covered by 2 analysts
Mereo BioPharma Group PLC ADR's activity chart (see below) currently has 22 price targets and 27 ratings on display. The stock rating distribution of MREO is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 7.41% with an average time for these price targets to be met of 113 days.
Highest price target for MREO is $3, Lowest price target is $2.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 10-Jul-2025. First documented stock forecast 10-Oct-2019.
Currently out of the existing stock ratings of MREO, 7 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$5
$3.13 (167.38%)
$7
1 years 2 months 21 days ago
(10-Jul-2025)
0/14 (0%)
$3.31 (195.86%)
Buy
$7
$5.13 (274.33%)
$7
1 years 6 months 13 days ago
(18-Mar-2025)
2/9 (22.22%)
$4.47 (176.68%)
339
Buy
$8
$6.13 (327.81%)
$8
2 years 3 months 11 days ago
(20-Jun-2024)
0/2 (0%)
$4.11 (105.66%)
What is MREO (Mereo BioPharma Group PLC ADR) average time for price targets to be met?
Which analyst most recently updated their price target on MREO (Mereo BioPharma Group PLC ADR)?
Which analyst has the current lower performing score on MREO (Mereo BioPharma Group PLC ADR) with a proven track record?
Which analyst has the most public recommendations on MREO (Mereo BioPharma Group PLC ADR)?
Which analyst is the currently most bullish on MREO (Mereo BioPharma Group PLC ADR)?
Which analyst is the currently most reserved on MREO (Mereo BioPharma Group PLC ADR)?
